62 results on '"Ollier, Edouard"'
Search Results
2. Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass
3. Loading dose of ceftazidime need to be increased in critically ill patients: a retrospective study to evaluate recommended loading dose with pharmacokinetic modeling
4. Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension
5. A framework to characterise the reproducibility of meta‐analysis results with its application to direct oral anticoagulants in the acute treatment of venous thromboembolism
6. Replication of systematic reviews: is it to the benefit or detriment of methodological quality?
7. Proteomic analysis of biomarkers associated with long-term survival in systemic sclerosis-related group 3 pulmonary hypertension in the HYPID study
8. Proteomic Biomarkers for Survival in Systemic Sclerosis-associated Pulmonary Hypertension
9. Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations
10. Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials
11. Adjusted versus fixed doses of LMWHs in trauma patients: A systematic review and meta-analysis
12. A retrospective study of the efficacy of intense pulsed light delivered by the Lacrystim® for meibomian gland dysfunction therapy
13. TNF-α and IL-1β Exposure Modulates the Expression and Functionality of P-Glycoprotein in Intestinal and Renal Barriers
14. Time impact on the antidiabetic effects of key bariatric surgeries: a network meta-analysis of randomized controlled trials with meta-regression
15. Time course response after single injection of botulinum toxin to treat spasticity after stroke: Systematic review with pharmacodynamic model-based meta-analysis
16. Development of a Bayesian estimation tool to determine the optimal duration of apixaban discontinuation before a high‐bleeding risk procedure
17. Fast selection of nonlinear mixed effect models using penalized likelihood
18. Robust K-PD model for activated clotting time prediction and UFH dose individualisation during cardiopulmonary bypass
19. In Vitro Evaluation of P-gp-Mediated Drug–Drug Interactions Using the RPTEC/TERT1 Human Renal Cell Model
20. Penalized Poisson model for network meta‐analysis of individual patient time‐to‐event data
21. Functional, proteomic and phenotypic in vitro studies evidence podocyte injury after chronic exposure to heparin
22. Impact of a restrictive antibiotic policy on the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an endemic region: a before-and-after, propensity-matched cohort study in a Caribbean intensive care unit
23. An epidemic of redundant meta‐analyses
24. Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study
25. Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach
26. PHILEOS (haemoPHILia and ostEoporOSis) Study: protocol of a multicentre prospective case–control study
27. Prevention of Venous Thromboembolic Events in Patients with Lower Leg Immobilization after Trauma: Systematic Review and Network Meta-Analysis with Meta-Epidemiological Approach
28. Exposure–Response Relationship of Tranexamic Acid in Cardiac Surgery
29. Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer
30. How many patients recover from acute kidney injury after pulmonary embolism?
31. Conservative versus Surgical Treatment for Odontoid Fracture: Is the Surgical Treatment Harmful? Systematic Review and Meta-Analysis
32. Early detection of the existence or absence of the treatment effect: A cumulative meta-analysis
33. Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism
34. Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis
35. Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis
36. A new paradigm for personalized prophylaxis for patients with severe haemophilia A
37. Chemoradiation phase II trials: re-exploring a world of missed opportunities
38. Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model‐based meta‐analytic approach
39. Dose tailoring of human cell line‐derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A
40. L’existence d’une dysplasie acétabulaire modifie-t-elle le résultat du traitement arthroscopique du conflit fémoro-acétabulaire par effet came ? Étude cas témoin chez des patients avec et sans dysplasie acétabulaire
41. Does acetabular dysplasia affect outcome in arthroscopic treatment of cam femoroacetabular impingement? Case-control study with and without acetabular dysplasia
42. Renal Function Assessment and Bleeding Prediction in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
43. Les patients atteints d’un conflit fémoro-acétabulaire associé à une coxarthrose modérée, sont-ils de bons candidats au traitement arthroscopique ?
44. SP466MODEL BASED META-ANALYSIS OF VANCOMYCIN CLEARANCE DURING RENAL REPLACEMENT THERAPY: APPLICATION TO VANCOMYCIN PHARMACOKINETIC DURING SLED IN ICU PATIENTS
45. Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers
46. Stochastic proximal-gradient algorithms for penalized mixed models
47. Dual “mAb” HER family blockade in head and neck cancer human cell lines combined with photon therapy
48. Hemorrhagic and thrombotic events in oncology patients treated with antiangiogenic therapy: Impact of study design on the results assessed by meta-analysis.
49. Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism
50. Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.